ACE2 and COVID-19: Recently, by exploring different biomarkers in a cohort of COVID-19 patients (30 prolonged viral shedders and 14 short viral shedders) we found that circulating blood cells (in particular monocytes) from COVID-19 patients expressed less ACE2 mRNA than cells from healthy volunteers (Osman et al., 2021).